Plasma and synovial fluid concentrations of nimesulide and its main metabolite after a single or repeated oral administration in patients with knee osteoarthritis

Journal of International Medical Research

Volumn 34, Issue 4, 2006, Pages 348-354

  Bianchi, Mauro ^a   Ferrario, P ^a   Balzarini, P ^b   Broggini, M ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b OSPEDALE DI CIRCOLO   (Italy)

Author keywords

Hydroxynimesulide (M1); Nimesulide; Non steroidal anti inflammatory drugs (NSAIDs); Osteoarthritis; Plasma; Synovial fluid

Indexed keywords

DRUG METABOLITE; HYDROXYNIMESULIDE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG;

AGED; ANALGESIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG SYNOVIAL FLUID LEVEL; FEMALE; HUMAN; KNEE OSTEOARTHRITIS; KNEE PAIN; MALE; SINGLE DRUG DOSE;

EID: 33748554804     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000603400402     Document Type: Article

References (29)

1. Bennett A: Nimesulide: a well-established cyclooxygenase-2 inhibitor with many other pharmacological properties relevant to inflammatory diseases. In: Therapeutic Roles of Selective COX-2 Inhibitors (Vane JJ, Botting RM, eds). London: William Harvey Press, 2001; pp524-540.
2. Rainsford KD (ed): Nimesulide. Actions and Uses. Basel: Birkhäuser, 2005.
3. Davis R, Brogden RN: Nimesulide. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. Drugs 1994; 48: 431-454.
4. Huskisson EC: Nimesulide, a balanced drug for the treatment of osteoarthritis. Clin Exp Rheumatol 2001; 19 (Suppl 22): S21-S25.
5. Bianchi M, Broggini M: A randomised, double-blind, clinical trial comparing the efficacy of nimesulide, celecoxib and rofecoxib in osteoarthritis of the knee. Drugs 2003; 63 (Suppl 1): 37-46.
6. Bernareggi A: Clinical pharmacokinetics of nimesulide. Clin Pharmacokinet 1998; 35: 247-274.
7. Castoldi D, Monzani V, Tofanetti O: Simultaneous determination of nimesulide and hydroxynimesulide in human plasma and urine by high-performance liquid chromatography. J Chromatogr 1988; 425: 413-418.
8. Bernareggi A: The pharmacokinetic profile of nimesulide in healthy volunteers. Drugs 1993; 46 (Suppl 1): 64-72.
9. Maffei-Facino R, Carini M, Aldini G: Anti-oxidant activity of nimesulide and its main metabolite. Drugs 1993; 46 (Suppl 1): 15-21.
10. Lignière GC, Tamborini U, Panarace G: La nimesulide nel liquido sinoviale di pazienti con artrite reumatoide. Farmaci e Terapia 1990; 7: 173-176.
11. 2 production by nimesulide compared with diclofenac in the acutely inflamed joints of patients with arthritis. Drugs 2003; 63 (Suppl 1): 31-36.
12. Netter P, Bannwarth B, Royer-Morrot MJ: Recent findings on the pharmacodynamics of non-steroidal anti-inflammatory drugs in synovial fluid. Clin Pharmacokinet 1989; 17: 145-162.
13. Altman RD: Criteria for classification of osteoarthritis of the knee and hip. Scand J Rheumatol Suppl 1987; 65: 31-39.
14. Ferrario P, Bianchi M: Simultaneous determination of nimesulide and hydroxynimesulide in rat plasma, cerebrospinal fluid and brain by liquid chromatography using solid-phase extraction. J Chromatogr B Analyt Technol Biomed Life Sci 2003; 785: 227-236.
15. Blardi P, Gatti F, Auteri A, Di Perri T: Effectiveness and tolerability of nimesulide in the treatment of osteoarthritic elderly patients. Int J Tissue React 1992; 14: 263-268.
16. Bourgeois P, Dreiser RL, Lequesne MG, Macciocchi A, Monti T. Multi-centre double-blind study to define the most favourable dose of nimesulide in terms of efficacy/safety ratio in the treatment of osteoarthritis. Eur J Rheum Inflamm 1994; 14: 39-50.
17. Porto A, Almeida H, Cunha MJ, Macciocchi A: Double-blind study evaluating by endoscopy the tolerability of nimesulide and diclofenac on the gastric mucosa in osteoarthritic patients. Eur J Rheumatol Inflamm 1994; 14: 33-38.
18. Wober W: Comparative efficacy and safety of nimesulide and diclofenac in patients with acute shoulder, and a meta-analysis of controlled studies with nimesulide. Rheumatology 1999; 38 (Suppl 1): 33-38.
19. Huskisson EC, Macciocchi A, Rahlfs VW, Bernstein RM, Bremner AD, Doyle DV, et al: Nimesulide versus diclofenac in the treatment of osteoathritis of the hip or knee: an active controlled equivalence study. Curr Ther Res 1999; 60: 253-265.
20. Sharma S, Rastogi S, Gupta V, Rohtagi D, Gulati P: Comparative efficacy and safety of nimesulide versus piroxicam in osteoarthritis with special reference to chondroprotectian. Am J Ther 1999; 6: 191-197.
21. Kriegel W, Korff KJ, Ehrlich JC, Lehnhardt K, Macciocchi A, Moresino C, et al: Double-blind study comparing the long-term efficacy of the COX-2 inhibitor nimesulide and naproxen in patients with osteoarthritis. Int J Clin Pract 2001; 55: 510-514.
22. Strusberg A, Montrull H, Meirovich CI: Anti-prostaglandin and anti-inflammatory short-term efficacy of piroxicam in rheumatoid arthritis. Eur J Rheumatol Inflamm 1983; 6: 41-45.
23. Gallo JM, Gall EP, Gillespie WR, Albert KS, Perrier D: Ibuprofen kinetics in plasma and synovial fluid of arthritic patients. J Clin Pharmacol 1986; 26: 65-70.
24. Borenstein D: Synovial tissue, synovial fluid, and plasma distribution of nonsteroidal anti-inflammatory drugs: clinical implications. Am J Ther 1995; 2: 978-983.
25. Steinmeyer J: Pharmacological basis for the therapy of pain and inflammation with non-steroidal anti-inflammatory drugs. Arthritis Res 2000; 2: 379-385.
26. Hinz B, Brune K: Cyclooxygenase-2 - 10 years later. J Pharmacol Exp Ther 2002; 300: 367-375.
27. Giuliano F, Ferraz JG, Pereira R, de Nucci G, Warner TD: Cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs in humans: ex vivo evaluation, Eur J Pharmacol 2001; 426: 95-103.
28. Pulkkinen MO: Is there a rationale for the use of nimesulide in the treatment of dysmenorrhoea? Drugs Today 2001; 37 (Suppl B): 31-38.
29. Bianchi M, Broggini M: Anti-hyperalgesic effects of nimesulide: Studies in rats and humans. Int J Clin Practice 2002; 128 (Suppl): 11-19.